Aastrom Biosciences, Inc. to Present at the JMP Securities Healthcare Conference
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ANN ARBOR, Mich., July 3, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that Nick Colangelo, president and CEO of Aastrom, will present at the 8th Annual JMP Securities Healthcare Conference on Tuesday, July 9 at 2:00 p.m. ET at the St. Regis New York. A copy of the presentation will be available on the company's website at http://investors.aastrom.com/events.cfm.
Help employers find you! Check out all the jobs and post your resume.
ANN ARBOR, Mich., July 3, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that Nick Colangelo, president and CEO of Aastrom, will present at the 8th Annual JMP Securities Healthcare Conference on Tuesday, July 9 at 2:00 p.m. ET at the St. Regis New York. A copy of the presentation will be available on the company's website at http://investors.aastrom.com/events.cfm.
Help employers find you! Check out all the jobs and post your resume.